yu
lung
lau
js
malik
peiri
sever
acut
respiratori
syndrom
sar
zoonot
infecti
diseas
caus
novel
coronaviru
cov
tissu
tropism
sarscov
includ
lung
also
gastrointestin
tract
kidney
liver
angiotensinconvert
enzym
ctype
lectin
also
known
lsign
dcsign
bind
sarscov
appear
key
function
receptor
viru
promin
innat
immun
respons
sarscov
infect
includ
acutephas
protein
chemokin
inflammatori
cytokin
ctype
lectin
mannosebind
lectin
play
protect
role
sar
contrast
may
lack
type
interferon
respons
moreov
lymphopenia
decreas
number
cell
common
acut
phase
convalesc
patient
iggclass
neutral
antibodi
recogn
amino
acid
spike
protein
protein
major
epitop
sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
appear
guangdong
provinc
peopl
republ
china
novemb
spread
global
infect
peopl
death
month
etiolog
agent
identifi
coronaviru
cov
genom
sequenc
establish
novel
member
famili
novel
cov
satisfi
koch
postul
causat
includ
consist
detect
viru
antibodi
respons
viru
patient
sar
reproduct
diseas
nonhuman
primat
experiment
inocul
previou
review
address
issu
clinic
present
aetiolog
laboratori
diagnosi
epidemiolog
viral
genet
vaccin
therapeut
public
health
focu
hostpathogen
interact
includ
tropism
sarscov
viral
entri
host
cell
innat
adapt
immun
respons
host
genet
suscept
sar
tropism
anim
human
market
sell
live
poultri
fish
human
consumpt
wet
market
common
place
across
southeast
asia
servic
cultur
demand
freshli
kill
meat
poultri
product
part
southern
china
guangdong
provinc
particular
increas
affluenc
result
larg
market
hous
divers
anim
includ
reptil
mammalian
speci
serv
restaur
trade
exot
food
sarscovlik
virus
isol
himalayan
palm
civet
found
wildlif
wet
market
guangdong
figur
serolog
evid
infect
raccoon
dog
human
market
also
found
support
zoonot
origin
sar
anim
cov
isol
differ
human
sarscov
addit
sequenc
found
human
isol
addit
sequenc
anim
cov
result
merg
open
read
frame
orf
new
orf
encod
put
protein
amino
acid
unknown
biolog
signific
precursor
anim
cov
adapt
human
achiev
effici
mantoman
transmiss
remain
unknown
molecular
epidemiolog
studi
sarscov
suggest
sever
introduct
anim
cov
human
occur
one
delet
associ
subsequ
outbreak
hong
kong
spread
global
phylogenet
analysi
human
case
guangdong
decemb
reveal
sarscov
much
closer
palm
civet
cov
human
sarscov
detect
epidem
earli
strengthen
content
sar
zoonot
origin
wet
market
serv
continu
sourc
sarscov
cross
speci
anim
human
tropism
lung
multipl
organ
sar
larg
viral
pneumonia
lung
patholog
show
diffus
alveolar
damag
multinucl
giantcel
promin
increas
macrophag
alveoli
lung
interstitium
apart
pneumonia
patient
respect
diarrhoea
two
separ
cohort
patient
despit
activ
viral
replic
enterocyt
minim
disrupt
intestin
architectur
cellular
infiltr
mechan
pathogenesi
diarrhoea
remain
unclear
absenc
intestin
inflamm
destruct
specul
result
upregul
potent
immunosuppress
cytokin
tgfb
antiapoptot
host
cellular
respons
intestin
epitheli
cell
respect
use
immunohistochemistri
situ
hybrid
examin
organ
four
sar
patient
die
sarscov
found
lung
intestin
also
liver
distal
convolut
renal
tubul
sweat
gland
parathyroid
pituitari
pancrea
adren
gland
cerebrum
use
reversetranscriptas
polymeras
chain
reaction
examin
fatal
sar
case
sarscov
rna
detect
lung
small
larg
bowel
lymph
node
spleen
liver
heart
kidney
skelet
muscl
descend
order
viral
load
per
gram
tissu
find
suggest
sar
system
diseas
widespread
extrapulmonari
dissemin
result
viral
shed
respiratori
secret
stool
urin
possibl
even
sweat
organ
damag
patient
sar
could
due
local
viral
replic
immunopatholog
consequ
host
respons
henc
import
delin
human
cell
sarscov
infect
replic
well
subsequ
host
immun
respons
coronavirus
includ
sarscov
associ
cellular
receptor
mediat
infect
target
cell
via
surfac
spike
protein
protein
figur
metallopeptidas
angiotensinconvert
enzym
shown
function
receptor
sarscov
amino
acid
sarscov
protein
critic
interact
sarscov
protein
strike
similar
class
fusion
protein
includ
influenza
viru
haemagglutinin
paramyxoviru
f
protein
ntermin
half
protein
contain
receptorbind
domain
wherea
ctermin
half
membraneanchor
membranefus
subunit
contain
two
heptad
repeat
region
bind
target
cell
transmembran
protein
chang
conform
associ
region
form
sixhelix
oligomer
complex
lead
fusion
viral
targetcel
membran
xray
crystallograph
structur
sarscov
fusionprotein
core
provid
framework
design
entri
inhibitor
apart
direct
membran
fusion
target
cell
surfac
sarscov
might
gain
cell
entri
via
phdepend
endocytosi
also
mediat
protein
furthermor
glycosyl
protein
shown
bind
ctype
lectin
dcsign
dcspecif
nonintegrin
express
dc
cell
mediat
sarscov
infect
tran
cell
express
human
dcsign
initi
sarscov
entri
dc
human
also
known
liverlymphnodespecif
l
sign
ident
human
dcsign
also
bind
protein
mediat
viru
entri
role
initi
product
viru
replic
remain
unclear
protein
reportedli
present
type
type
pneumocyt
enterocyt
part
small
intestin
brush
border
proxim
tubular
cell
kidney
well
endotheli
cell
small
larg
arteri
vein
tissu
studi
arteri
smooth
muscl
cell
local
explain
tissu
tropism
sarscov
lung
small
intestin
kidney
howev
notabl
discrep
includ
viru
replic
colon
epithelium
viru
infect
endotheli
cell
receptor
coreceptor
lsign
may
explain
discrep
sinc
basal
layer
nonkeratin
squamou
epithelium
upper
respiratori
tract
express
undamag
epithelium
nasopharynx
like
support
sarscov
replic
rais
interest
possibl
preced
infect
anoth
pathogen
may
expos
basal
layer
facilit
sarscov
infect
damag
upper
respiratori
tract
spread
involv
lung
furthermor
may
partli
explain
longer
incub
period
mean
day
varianc
day
sar
gradual
increas
viral
load
nasopharyng
aspir
sar
patient
first
day
ill
compar
influenza
sinc
sarscov
may
take
longer
time
influenza
viru
establish
infect
respiratori
tract
gradual
increas
viral
load
first
day
sar
also
suggest
viru
may
evad
innat
immun
defenc
host
may
relev
sarscov
infect
human
macrophag
vitro
lead
initi
viral
replic
viral
protein
synthesi
without
detect
interferon
respons
furthermor
mark
contrast
patient
influenza
lack
express
mrna
interferon
interferon
b
peripher
blood
mononuclear
cell
patient
sar
hand
innat
immun
defenc
collectin
bind
glycosyl
sarscov
protein
may
play
import
role
host
defenc
collectin
includ
lung
surfact
protein
well
mannosebind
lectin
mbl
present
serum
casecontrol
geneassoci
studi
hong
kong
chines
sar
patient
healthi
control
lowmblproduc
genotyp
shown
associ
increas
risk
sar
moreov
mbl
bind
sarscov
result
protect
biolog
effect
calciumdepend
mannaninhibit
fashion
suggest
bind
carbohydraterecognit
domain
mbl
protein
plasma
proteom
analysi
four
patient
reveal
activ
innat
immun
respons
sarscov
includ
increas
acutephas
protein
serum
amyloid
ctype
lectin
mbl
tetranectin
observ
suggest
mbl
play
protect
role
develop
sar
highdens
oligonucleotid
array
analysi
geneexpress
chang
peripher
blood
mononuclear
cell
normal
healthi
donor
inocul
vitro
sarscov
show
earli
activ
innat
immun
pathway
first
h
includ
enhanc
express
tolllik
receptor
cc
chemokin
receptor
pattern
indic
rapid
mobil
increas
traffick
monocytemacrophag
lineag
lung
earli
infect
anoth
studi
sarscov
shown
induc
chemokin
releas
lung
epitheli
cell
fibroblast
via
amino
acid
protein
addit
protein
structur
n
protein
found
activ
promot
lung
cell
well
model
sarscov
infect
mice
show
increas
product
proinflammatori
chemokin
receptor
lung
surprisingli
cytokin
interferong
detect
littl
pulmonari
infiltr
moreov
beig
mice
clear
sarscov
normal
observ
suggest
proinflammatori
chemokin
may
coordin
highli
effect
innat
antivir
respons
lung
nk
cell
adapt
cellular
immun
requir
viral
clearanc
speci
hand
appear
contribut
host
defenc
sarsinfect
mice
defici
lead
resist
antivir
effect
interferon
may
relev
observ
cytokin
chemokin
measur
plasma
sar
patient
difficult
interpret
partli
mani
confound
factor
diseas
cours
nevertheless
chemokin
inflammatori
cytokin
found
elev
patient
interestingli
prolong
disturb
vitro
cytokin
product
sar
patient
also
demonstr
lymphopenia
rapid
decreas
cell
common
acut
phase
sar
may
associ
advers
outcom
recov
patient
rapid
restor
cell
subset
seen
mechan
underli
acut
lymphopenia
remain
unclear
may
relat
induc
apoptosi
uninfect
lymphocyt
measl
sinc
consist
absenc
b
lymphocyt
macrophag
haematolymphoid
organ
suggest
direct
viral
infect
may
caus
overexpress
protein
specif
encod
sarscov
induc
apoptosi
via
caspasedepend
pathway
cell
line
deriv
differ
organ
includ
lung
liver
kidney
express
may
one
underli
mechan
pathogenesi
sarscov
infect
detect
serum
igg
igm
iga
sarscov
use
immunofluoresc
assay
elisa
nucleocapsid
antigen
occur
around
time
patient
seroconvert
day
onset
ill
igg
detect
earli
day
onset
ill
kinet
neutral
antibodi
nearli
parallel
igg
neutralizingantibodi
activ
attribut
igg
studi
sar
patient
neutralizingantibodi
level
peak
day
sustain
day
antibodi
neutral
pseudotyp
particl
bear
protein
differ
sarscov
strain
suggest
antibodi
broadli
activ
protein
highli
immunogen
inde
protein
among
structur
protein
e
n
signific
sarscov
neutral
antigen
protect
antigen
amino
acid
major
immunodomin
epitop
human
monoclon
antibodi
shown
nanomolar
affin
potent
neutral
sarscov
infect
inhibit
syncytia
format
block
receptor
bind
epitop
locat
within
ntermin
amino
acid
protein
glycosylationdepend
immort
memori
b
cell
sar
patient
recov
also
enabl
isol
human
monoclon
antibodi
potent
neutral
sarscov
antibodi
two
pattern
stain
protein
neutral
activ
antibodi
highavid
bind
spike
transfect
neutral
titer
proport
degre
bind
wherea
other
lowavid
bind
spite
effici
viral
neutral
b
cell
memori
repertoir
patient
analyz
approach
studi
function
effect
sprotein
mutat
term
affin
cellular
receptor
sensit
antibodi
neutral
viral
pseudotyp
substanti
function
chang
found
sprotein
deriv
case
late
guangdong
depend
much
less
receptor
cell
entri
markedli
resist
antibodi
neutral
comparison
eight
strain
transmit
human
outbreak
earli
moreov
antibodi
neutral
human
protein
enhanc
entri
mediat
palm
civet
viru
protein
underscor
need
address
evolv
divers
sarscov
vaccin
develop
progress
experiment
vaccin
candid
sar
previous
review
insight
mechan
antibodydepend
enhanc
help
avoid
complic
vaccin
develop
inabl
maintain
use
vitro
cultur
anim
sarscov
precursor
viru
palm
civet
make
difficult
confirm
whether
find
pseudotyp
viru
relev
infecti
sarscovlik
viru
isol
altern
approach
address
question
use
techniqu
sarscov
revers
genet
becom
avail
cytotox
tcell
respons
major
specif
defenc
viral
infect
two
tcell
epitop
capabl
elicit
tcell
respons
patient
recov
sarscov
infect
identifi
sinc
sar
entir
new
diseas
offer
uniqu
opportun
studi
genet
innat
immun
sar
popul
level
mention
individu
carri
lowmblproduc
haplotyp
yb
odd
ratio
develop
sar
associ
hlab
sarscov
infect
report
studi
sar
patient
taiwan
confirm
anoth
studi
patient
hong
kong
instead
found
signific
associ
hlab
hladr
develop
sar
gene
polymorph
associ
sar
suscept
outcom
studi
patient
healthi
control
although
much
learnt
sar
two
year
sinc
discoveri
aspect
pathogenesi
diseas
still
fulli
understood
human
case
sar
anim
model
accur
reflect
human
diseas
review
although
kinet
protect
role
host
antibodi
respons
better
defin
role
adapt
cellmedi
innat
immun
respons
sar
still
unravel
empir
approach
vaccin
develop
progress
rapidli
remain
import
better
elucid
mechan
diseas
pathogenesi
minim
risk
unpleasantli
surpris
unintend
consequ
vaccin
lack
binterferon
respons
cell
infect
sar
cov
document
two
cell
cultur
model
vitro
human
primari
myeloidderiv
dc
epitheli
cell
line
sar
cov
induc
nuclear
transloc
interferon
regulatori
factor
irf
cell
propos
lack
interferon
respons
due
block
subsequ
dimer
hyperphosphoryl
